IQVIA Seat License

Pursuant to, FAR 13.106(1) (b), Soliciting from a single source, (1) for purchases not exceeding the simplified acquisition threshold, (i) Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name or industrial mobilization). The Centers for Disease Control and Prevention (CDC), Centers for Surveillance, Epidemiology and Laboratory Services (CSELS), Division of Laboratory Services (DLS) needs an additional IQVIA Seat License for access to IQVIA’s E360 platform and tools, including access to PharMetrics plus and longitudinal cohorts, and downloads of data for analysis outside the platform. IQVIA™ is considered The Human Data Science Company™ focused on using data and science to help healthcare clients find better solutions for their patients. IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. Any questions regarding this notice shall be submitted in writing ONLY to Berta Alldredge at [email protected] . The anticipated date of award is Aug 28, 2020. It is your responsibility to keep up with additional postings regarding this announcement on the Fedbizopps Website. Telephone inquiries will not be honored.